No search results found for 'searchTerm'
Registration, Account & Password
-
-
New customers can sign up for an account by visiting 'Join Allergan Advantage'. Here you can enter your details and clinic practice information.
-
-
Our Customer Service team will verify your details and set up your account within a week.
-
-
If you need to change or edit any of your account details, for example your shipping address, please contact Customer Service on 1800 252 224 and we will process these changes for you.
-
-
If you have forgotten your password, you can reset it by accessing the login portal and selecting 'Forgot Password'. If you cannot remember your login email, please contact Customer Service on 1800 252 224.
Adverse Events and Claims
-
-
Pharmaceutical companies are legally required to collect and report any adverse events related to their products. Where a complication has arisen and an Allergan Aesthetics product is involved, it is important to report this event as quickly as possible.
To report an adverse event or side effect, please visit allerganaesthetics.com.au/about/report-an-adverse-event.
Product/Education
-
-
For general enquires about Allergan Aesthetic products, please contact Customer Service on 1800 252 224.
For medical enquiries regarding an Allergan Aesthetics product, please contact the Medical Information department, by phone: 1800 252 224 (select option 4) or email: medinfoanz@abbvie.com -
-
We can offer you a Skype call to go through the products and answer any specific questions at a time that is convenient for you. Please submit a request to contact the Customer Service Team, who will book your call with a Product Specialist.
Training and Commercial
-
-
To become a customer, please speak with our Customer Service team on 1800 252 224, who will take your contact information and healthcare professional specialty.
Customer Service
Questions + Feedback
Contact us if you have a question for the Allergan Advantage team or feel free to submit any website feedback.
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://www.allerganaesthetics.com.au/about/report-an-adverse-event
References:
- Fagien S et al. Dermatol Surg 2017;43:S274–S284.
- Allergan, BOTOX® Approved Product Information.
- Kukreja K and Singh BR. Res Rep Biochem 2015;5:173–83.
- Beer KR et al. J Drugs Dermatol 2011;10(1):39–44.
- Glogau R et al. Dermatol Surg 2012;38(11):1794–803.
- Lowe NJ et al. Dermatol Surg 2005;31(3):257–62.
- Solish N et al. Dermatol Surg 2016;42:410–9.
- Dailey RA et al. Dermatol Surg 2011;37(7):918–28.
- Allergan, JUVÉDERM® VOLITETM Instructions For Use.
- Allergan, JUVÉDERM® VOLBELLA® with Lidocaine Instructions For Use.
- Allergan, JUVÉDERM® VOLIFT® with Lidocaine Instructions For Use.
- Allergan, JUVÉDERM® VOLUMA® with Lidocaine Instructions For Use.
- Allergan, JUVÉDERM® VOLUXTM Instructions For Use.
- Allergan, JUVÉDERM® ULTRA XC Instructions For Use.
- Allergan, JUVÉDERM® ULTRA PLUS XC Instructions For Use.
- Beer K and Solish N. J Drugs Dermatol 2009;8(12):1086–91.
- Goodman GJ et al. Plast Reconstr Surg 2015;136(5 Suppl):139S–48S.
- Raspaldo H. J Cosmet Laser Ther 2008;10(3):134–42.
- Allergan, JUVÉDERM® VOLUXTM Evaluated Data.
- Eccleston D and Murphy DK. Clin Cosmet Investig Dermatol 2012;5:167–72.
- Pinsky MA et al. Aesthet Surg J 2008;28(1):17–23.
- Niforos F et al. Clin Cosmet Investig Dermatol 2019;12:791–8.
- Callan P et al. Clin Cosmet Investig Dermatol 2013;6:81–9.
- Jones D and Murphy DK. Dermatol Surg 2013;39:1602–12.
- Niforos F et al. Dermatol Surg 2017;43(10):1271–80.
- Dayan S et al. Aesthet Surg J 2020;40(7):767–77.
- Dayan S et al. Dermatol Surg 2015;41:S293–S301.
- Muhn C et al. Clin Cosmet Investig Dermatol 2012;5:147−58.
- Carruthers JD et al. Plast Reconstr Surg 2008;121(Suppl 5):5S–30S.
- Liew S et al. J Cosmet Dermatol 2020;19(2):296–302.